Medicine information REDITENS 90mg film-coated tablets
- Product code:
- W66802001
- Quantity:
- 30
- Indicated for:
- iron overload
- Route of administration:
- oral
- Substance:
- deferasirox (chelating agent)
- ATC
- V03AC03 — Various | All other therapeutic products | All other therapeutic products | Iron chelating agents
The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.
Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.
This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.
General data about REDITENS 90mg
- Substance:
- deferasirox
- Date of latest medicines list:
- 01-10-2026
- Product code:
- W66802001
- Strength:
- 90mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Price:
- 102.51 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for deferasirox
Strengths available for deferasirox
- 125mg
- 180mg
- 250mg
- 360mg
- 500mg
- 90mg
Reimbursement lists for REDITENS 90mg Dr. Reddy's
G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors
- Price
- 102.51 RON
- Copayment
- 102.51 RON
- Patient payment
- 0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
- Price
- 102.51 RON
- Copayment
- 102.51 RON
- Patient payment
- 0.00 RON
NHP 6.1 (C2) - Hemophilia and thalassemia
- Price
- 102.51 RON
- Copayment
- 102.51 RON
- Patient payment
- 0.00 RON
NHP 9.1 (C2) - Spinal cord transplant
- Price
- 102.51 RON
- Copayment
- 102.51 RON
- Patient payment
- 0.00 RON